Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Enanta Pharmaceutica (ENTA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,893,038
  • Shares Outstanding, K 19,380
  • Annual Sales, $ 102,810 K
  • Annual Income, $ 17,710 K
  • 36-Month Beta 0.87
  • Price/Sales 17.36
  • Price/Cash Flow 85.59
  • Price/Book 4.92

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate 1.21
  • Number of Estimates 4
  • High Estimate 1.31
  • Low Estimate 1.16
  • Prior Year 1.86
  • Growth Rate Est. (year over year) -34.95%

Price Performance

See More
Period Period Low Period High Performance
1-Month
86.52 +9.11%
on 09/06/18
98.08 -3.75%
on 09/21/18
+2.17 (+2.35%)
since 08/21/18
3-Month
81.24 +16.20%
on 08/08/18
127.77 -26.12%
on 07/06/18
-24.59 (-20.67%)
since 06/21/18
52-Week
42.49 +122.17%
on 09/22/17
127.77 -26.12%
on 07/06/18
+50.55 (+115.28%)
since 09/21/17

Most Recent Stories

More News
Enanta Pharmaceuticals to Present New Data on its RSV Inhibitor EDP-938 at the 11th International Respiratory Syncytial Virus Symposium

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a research and development-focused biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today...

ENTA : 94.34 (-3.42%)
Enanta Pharmaceuticals to Present at Two Upcoming Investor Conferences

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a research and development-focused biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today...

ENTA : 94.34 (-3.42%)
Enanta Pharmaceuticals (ENTA) Q3 Earnings and Revenues Top Estimates

Enanta Pharmaceuticals (ENTA) delivered earnings and revenue surprises of 1.04% and 1.19%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?

ENTA : 94.34 (-3.42%)
Enanta Pharmaceuticals: Fiscal 3Q Earnings Snapshot

WATERTOWN, Mass. (AP) _ Enanta Pharmaceuticals Inc. (ENTA) on Tuesday reported fiscal third-quarter net income of $20.3 million, after reporting a loss in the same period a year earlier.

ENTA : 94.34 (-3.42%)
Why Earnings Season Could Be Great for Enanta Pharmaceuticals (ENTA)

Enanta Pharmaceuticals (ENTA) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

ENTA : 94.34 (-3.42%)
Enanta Pharmaceu Has Returned 16.5% Since SmarTrend Recommendation (ENTA)

SmarTrend identified an Uptrend for Enanta Pharmaceu (NASDAQ:ENTA) on June 6th, 2018 at $104.09. In approximately 1 month, Enanta Pharmaceu has returned 16.46% as of today's recent price of $121.22.

ENTA : 94.34 (-3.42%)
Enanta Pharmaceu Rises 4.32% on Heavy Volume: Watch For Potential Pullback

Enanta Pharmaceu (NASDAQ:ENTA) traded in a range yesterday that spanned from a low of $117.98 to a high of $124.14. Yesterday, the shares gained 4.3%, which took the trading range above the 3-day high...

ENTA : 94.34 (-3.42%)
5 Top Performing Stocks of the Best ETF of 1H2018

Inside the top performing stocks of the top ETF of the first half of 2018.

TCMD : 64.57 (+0.16%)
SRDX : 72.82 (+0.03%)
ENTA : 94.34 (-3.42%)
RGNX : 69.55 (-2.80%)
PSCH : 140.33 (-0.90%)
TRHC : 76.64 (-1.97%)
5 Top Performing Stocks of the Best ETF of 1H2018

Inside the top performing stocks of the top ETF of the first half of 2018.

TCMD : 64.57 (+0.16%)
SRDX : 72.82 (+0.03%)
ENTA : 94.34 (-3.42%)
RGNX : 69.55 (-2.80%)
PSCH : 140.33 (-0.90%)
TRHC : 76.64 (-1.97%)
Achieve Life Sciences' Shares Rise on Positive Clinical Data

Achieve Life Sciences' (ACHV) pipeline candidate, cytisine, evaluated for smoking cessation, shows no significant interaction with other medication.

ENTA : 94.34 (-3.42%)
CTLT : 42.28 (-1.65%)
PFE : 44.02 (+0.62%)
ACHV : 2.51 (-1.86%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Trade ENTA with:

Business Summary

Enanta Pharmaceuticals, Inc. is a biotechnology company. It engages in the research and development of molecule drugs for the treatment of infectious diseases such as hepatitis C virus, respiratory tract infections, intravenous and oral treatments. Enanta Pharmaceuticals, Inc. is headquartered in Watertown,...

See More

Key Turning Points

2nd Resistance Point 101.35
1st Resistance Point 99.52
Last Price 94.34
1st Support Level 94.08
2nd Support Level 90.47

See More

52-Week High 127.77
Fibonacci 61.8% 95.19
Last Price 94.34
Fibonacci 50% 85.13
Fibonacci 38.2% 75.07
52-Week Low 42.49

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar